ONCY:NASDAQ
Oncolytics Biotech Inc
$0.80
arrow_downward
-4.53%(-0.038) 1D
$0.80
arrow_downward
-0.62% (-0.0050)bedtimeAfter hours
Closed: Sep 8, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ONCY...
Open
$0.83
High
$0.84
Low
$0.79
Mkt. cap
103.04M
Avg. vol.
698.22K
Volume
1.14M
52-wk high
$1.51
52-wk low
$0.73
Beta
1.15
Shares outstanding
127.51M
No. of employees
29
Open
$0.83
High
$0.84
Low
$0.79
Mkt. cap
103.04M
Avg. vol.
698.22K
Volume
1.14M
52-wk high
$1.51
52-wk low
$0.73
Beta
1.15
Shares outstanding
127.51M
No. of employees
29
Profile
Oncolytics Biotech Inc. is a biotech company headquartered in San Diego, California, that is developing an intravenously delivered immuno-oncolytic virus called pelareorep for the treatment of solid tumors and hematological malignancies. Pelareorep is a non-pathogenic, proprietary isolate of the unmodified reovirus that induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses. Wikipedia
About Oncolytics Biotech Inc
CEO-
Employees29
Founded1998
HeadquartersCalgary, Alberta, Canada
SectorBiotechnology
Websiteoncolyticsbiotech.com